Trifluoroacetic Acid

Trifluoroacetic Acid

SCHEMBL4158314

C=CCOC(=O)CC[C@H](N)c1nc2cc(Cl)ccc2[nH]1.O=C(O)C(F)(F)F.O=C(O)C(F)(F)F

nearest known ligand 0.38

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
S1PR4 O95977 7/20 0.38
S1PR1 P21453 7/20 0.38
S1PR5 Q9H228 6/20 0.38
KDM4E B2RXH2 1/20 0.35
ALDH1A1 P00352 1/20 0.35
HPGD P15428 1/20 0.35
ATM Q13315 1/20 0.35
HSD17B10 Q99714 1/20 0.35
L3MBTL1 Q9Y468 1/20 0.35
MEN1 O00255 1/20 0.33
KMT2A Q03164 1/20 0.33
ROCK2 O75116 2/20 0.33
OPRM1 P35372 1/20 0.33
OPRD1 P41143 1/20 0.33
CTDSP1 Q9GZU7 1/20 0.33
SCN10A Q9Y5Y9 3/20 0.32
GAA P10253 1/20 0.32
TSHR P16473 1/20 0.32
PKM P14618 1/20 0.31
SMN1; SMN2 Q16637 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Trifluoroacetic Acid SCHEMBL4150060 1.00 S1PR4 (0.38) S1PR4S1PR1S1PR5KDM4EALDH1A1
Trifluoroacetic Acid SCHEMBL4150163 0.85 S1PR4 (0.40) S1PR4S1PR1S1PR5KDM4EMEN1
Trifluoroacetic Acid SCHEMBL4150312 0.85 S1PR4 (0.40) S1PR4S1PR1S1PR5KDM4EMEN1
Trifluoroacetic Acid SCHEMBL4157006 0.85 S1PR4 (0.40) S1PR4S1PR1S1PR5KDM4EMEN1
SCHEMBL5097390 0.83 HSD17B10 (0.39) KDM4EALDH1A1HPGDATMHSD17B10
Trifluoroacetic Acid SCHEMBL4166142 0.81 S1PR4 (0.45) S1PR4S1PR1S1PR5ROCK2OPRM1
Trifluoroacetic Acid SCHEMBL4156410 0.80 S1PR4 (0.51) S1PR4S1PR1S1PR5KDM4EOPRM1
SCHEMBL4148785 0.80 MAPT (0.42) KDM4EALDH1A1HPGDATMHSD17B10
SCHEMBL5111048 0.79 ENPP2 (0.41) KDM4EL3MBTL1MEN1KMT2AROCK2
SCHEMBL5110839 0.79 ENPP2 (0.41) KDM4EL3MBTL1MEN1KMT2AROCK2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090181958-A1 SUBSTITUTED NITROGEN-CONTAINING HETEROBICYCLES, THE PREPARATION THEREOF AND THEIR USE AS PHARMACEUTICAL COMPOSITIONS BOEHRINGER INGELHEIM PHARMA GMBH & CO. KG (DE) 2009-07-16 US disclosed
US-7429597-B2 Substituted nitrogen-containing heterobicycles, the preparation thereof and their use as pharmaceutical compositions BOEHRINGER INGELHEIM PHARMA GMBH & CO., KG (DE) 2008-09-30 US disclosed
US-20040176603-A1 Substituted nitrogen-containing heterobicycles, the preparation thereof and their use as pharmaceutical compositions BOEHRINGER INGELHEIM PHARMA GMBH & CO. KG (DE) 2004-09-09 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040176603-A1 Substituted nitrogen-containing heterobicycles, the preparation thereof and their use as pharmaceutical compositions F11, F12, F2 S1PR4 4711/4885S1PR1 3898/4885S1PR5 4042/4885
US-20090181958-A1 SUBSTITUTED NITROGEN-CONTAINING HETEROBICYCLES, THE PREPARATION THEREOF AND THEIR USE AS PHARMACEUTICAL COMPOSITIONS F12, F11, F2 S1PR4 4618/4885S1PR1 4147/4885S1PR5 4160/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.